A Phase IV Vaccine Study Under the National Cohort Study of Effectiveness and Safety of SARS-CoV-2 (COVID-19) Vaccines.

Conditions: SARS CoV 2 Infection Interventions: Biological: Johnson& Johnson Sponsors: Jens D Lundgren, MD; Ministry of the Interior and Health, Denmark Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials